5-hydroxytryptophan has been researched along with Aura in 21 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using our laboratory database, we identified patients with vitamin B6-dependent epilepsy and extracted their data on the concentrations of pyridoxal 5'-phosphate, pyridoxal, pipecolic acid, α-aminoadipic semialdehyde, and monoamine neurotransmitters." | 7.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "We aimed to demonstrate the biochemical characteristics of vitamin B6-dependent epilepsy, with a particular focus on pyridoxal 5'-phosphate and pyridoxal in the cerebrospinal fluid." | 7.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "We identified seven patients with pyridoxine-dependent epilepsy caused by an ALDH7A1 gene abnormality, two patients with pyridoxal 5'-phosphate homeostasis protein deficiency, and 28 patients with other epilepsies with low cerebrospinal fluid pyridoxal 5'-phosphate concentrations." | 7.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "Low cerebrospinal fluid pyridoxal concentrations may be a better indicator of pyridoxal 5'-phosphate deficiency in the brain in vitamin B6-dependent epilepsy than low cerebrospinal fluid pyridoxal 5'-phosphate concentrations." | 7.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "This study was designed to demonstrate a role of serotonin in the anticonvulsant effect of fluoxetine, a serotonin reuptake inhibitor, in genetically epilepsy-prone rats." | 7.69 | Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. ( Cheong, JH; Dailey, JW; Jobe, PC; Ko, KH; Yan, QS, 1994) |
| "Using our laboratory database, we identified patients with vitamin B6-dependent epilepsy and extracted their data on the concentrations of pyridoxal 5'-phosphate, pyridoxal, pipecolic acid, α-aminoadipic semialdehyde, and monoamine neurotransmitters." | 3.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "We aimed to demonstrate the biochemical characteristics of vitamin B6-dependent epilepsy, with a particular focus on pyridoxal 5'-phosphate and pyridoxal in the cerebrospinal fluid." | 3.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "We identified seven patients with pyridoxine-dependent epilepsy caused by an ALDH7A1 gene abnormality, two patients with pyridoxal 5'-phosphate homeostasis protein deficiency, and 28 patients with other epilepsies with low cerebrospinal fluid pyridoxal 5'-phosphate concentrations." | 3.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| "Low cerebrospinal fluid pyridoxal concentrations may be a better indicator of pyridoxal 5'-phosphate deficiency in the brain in vitamin B6-dependent epilepsy than low cerebrospinal fluid pyridoxal 5'-phosphate concentrations." | 3.96 | Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate. ( Akiyama, T; Baba, S; Dowa, Y; Fukuyama, T; Hamano, SI; Hasegawa, K; Hyodo, Y; Imai, K; Ishihara, N; Kobayashi, K; Koike, T; Kubota, M; Oboshi, T; Okanishi, T; Shibasaki, J; Shimbo, H; Shiraku, H; Takano, K; Takeshita, S; Yamamoto, T, 2020) |
| " Dietary restriction of phenylalanine and oral administration of amine precursors, L-dopa and 5-hydroxytryptophan had poor efficiency on epilepsy and psychomotor delay." | 3.70 | [Progressive convulsive encephalopathy: considering a abnormality of biopterin metabolism]. ( Dhondt, JL; Mikaeloff, Y; Pinton, F; Ponsot, G; Sevin, C, 1999) |
| "This study was designed to demonstrate a role of serotonin in the anticonvulsant effect of fluoxetine, a serotonin reuptake inhibitor, in genetically epilepsy-prone rats." | 3.69 | Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. ( Cheong, JH; Dailey, JW; Jobe, PC; Ko, KH; Yan, QS, 1994) |
| "In 6 patients with intention myoclonus, the cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid, a metabolite of serotonin was found to be significantly decreased." | 2.64 | Serotonin and myoclonus. ( Bowers, MB; Jutkowitz, R; Rosenbaum, D; Van Woert, MH, 1976) |
| "The 5-hydroxytryptophan content was much higher in both El groups." | 1.28 | Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice. ( Mori, A; Suzuki, S, 1992) |
| "The kynurenine content was remarkably high in the El mice." | 1.28 | Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice. ( Mori, A; Suzuki, S, 1992) |
| "Correlation between the kindled seizure susceptibility and brain monoamine levels was investigated in the hippocampal and amygdaloid kindled cats." | 1.26 | [Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation]. ( Mitsunobu, K; Nakashima, T; Otsuki, S; Sato, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (61.90) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Kayacan, Y | 1 |
| Ghojebeigloo, BE | 1 |
| Çerit, G | 1 |
| Kocacan, SE | 1 |
| Ayyıldız, M | 1 |
| Akiyama, T | 1 |
| Hyodo, Y | 1 |
| Hasegawa, K | 1 |
| Oboshi, T | 1 |
| Imai, K | 1 |
| Ishihara, N | 1 |
| Dowa, Y | 1 |
| Koike, T | 1 |
| Yamamoto, T | 1 |
| Shibasaki, J | 1 |
| Shimbo, H | 1 |
| Fukuyama, T | 1 |
| Takano, K | 1 |
| Shiraku, H | 1 |
| Takeshita, S | 1 |
| Okanishi, T | 1 |
| Baba, S | 1 |
| Kubota, M | 1 |
| Hamano, SI | 1 |
| Kobayashi, K | 1 |
| WADA, JA | 2 |
| García-Cazorla, A | 1 |
| Serrano, M | 1 |
| Pérez-Dueñas, B | 1 |
| González, V | 1 |
| Ormazábal, A | 1 |
| Pineda, M | 1 |
| Fernández-Alvarez, E | 1 |
| Campistol, JM | 1 |
| Artuch, RM | 1 |
| Sellinger, OZ | 1 |
| Dietz, DD | 1 |
| Yan, QS | 2 |
| Jobe, PC | 2 |
| Cheong, JH | 1 |
| Ko, KH | 1 |
| Dailey, JW | 2 |
| Mikaeloff, Y | 1 |
| Pinton, F | 1 |
| Sevin, C | 1 |
| Dhondt, JL | 1 |
| Ponsot, G | 1 |
| Sato, M | 1 |
| Nakashima, T | 1 |
| Mitsunobu, K | 1 |
| Otsuki, S | 1 |
| Kumashiro, H | 1 |
| Aono, T | 1 |
| Watanabe, K | 1 |
| Koizumi, S | 1 |
| Nakanishi, S | 1 |
| Kaneko, Y | 1 |
| Ohno, E | 1 |
| Uemura, S | 1 |
| Van Woert, MH | 1 |
| Jutkowitz, R | 1 |
| Rosenbaum, D | 1 |
| Bowers, MB | 1 |
| Chazot, G | 1 |
| Guard, O | 1 |
| Setiey, A | 1 |
| Robert, JM | 1 |
| Schott, B | 1 |
| Suzuki, S | 1 |
| Mori, A | 1 |
| Nakamura, M | 1 |
| Wada, Y | 1 |
| Hasegawa, H | 1 |
| Yamaguchi, N | 1 |
| Neuman, RS | 1 |
| Uldry, PA | 1 |
| Regli, F | 1 |
| Balzamo, E | 2 |
| Meldrum, BS | 2 |
| Naquet, R | 1 |
| Rohmer, F | 1 |
| Warter, JM | 1 |
| Coquillat, G | 1 |
| Maitrot, D | 1 |
| Kurtz, D | 1 |
| Micheletti, G | 1 |
| Mack, G | 1 |
| Mandel, P | 1 |
| Vuillon-Cacciuttolo, G | 1 |
| Sabouraud, O | 1 |
| Chatel, M | 1 |
| Badiche, A | 1 |
| Chauvel, P | 1 |
| Le Clec'h, G | 1 |
| Kolpakov, VG | 1 |
1 review available for 5-hydroxytryptophan and Aura
| Article | Year |
|---|---|
[Indications for L-5-hydroxytryptophan in neurology].
Topics: 5-Hydroxytryptophan; Down Syndrome; Epilepsy; Humans; Migraine Disorders; Myoclonus; Pain; Parkinson | 1987 |
2 trials available for 5-hydroxytryptophan and Aura
| Article | Year |
|---|---|
Serotonin and myoclonus.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Carbidopa; Clinical Trials as Topic; Epilepsy; Female; Homov | 1976 |
[Pharmacological and biochemical approach to a syndrome of action and intention myoclonus in the course of degenerative disease of the nervous system].
Topics: 5-Hydroxytryptophan; Adult; Benzazepines; Cerebellar Ataxia; Clinical Trials as Topic; Diagnosis, Di | 1973 |
18 other studies available for 5-hydroxytryptophan and Aura
| Article | Year |
|---|---|
Physical exercise and 5-hydroxytryptophan, a precursor for serotonin synthesis, reduce penicillin-induced epileptiform activity.
Topics: 5-Hydroxytryptophan; Animals; Epilepsy; Male; Penicillins; Quality of Life; Rats; Serotonin | 2020 |
Pyridoxal in the Cerebrospinal Fluid May Be a Better Indicator of Vitamin B6-dependent Epilepsy Than Pyridoxal 5'-Phosphate.
Topics: 5-Hydroxytryptophan; Adolescent; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Infant, | 2020 |
Epileptogenic cerebral electrical activity and serotonin levels.
Topics: 5-Hydroxytryptophan; Animals; Biochemical Phenomena; Brain; Cats; Epilepsy; Nervous System Physiolog | 1961 |
Secondary abnormalities of neurotransmitters in infants with neurological disorders.
Topics: 5-Hydroxytryptophan; Atrophy; Brain; Electroencephalography; Epilepsy; Female; Homovanillic Acid; Hu | 2007 |
The metabolism of 5-hydroxytryptamine in the methionine sulfoximine epileptogenic rat brain.
Topics: 5-Hydroxytryptophan; Animals; Brain; Epilepsy; Hydroxyindoleacetic Acid; Male; Methionine Sulfoximin | 1981 |
Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Epilepsy; Female; Fenclonine; Fluoxetine; Hydroxyindo | 1994 |
Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Disease Models, Animal; Drug Synergism; Epilepsy; Fem | 1994 |
[Progressive convulsive encephalopathy: considering a abnormality of biopterin metabolism].
Topics: 5-Hydroxytryptophan; Algeria; Anticonvulsants; Biopterins; Brain; Child, Preschool; Consanguinity; D | 1999 |
[Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation].
Topics: 5-Hydroxytryptophan; Amygdala; Animals; Brain Chemistry; Catecholamines; Cats; Dopamine; Electric St | 1976 |
DC potential shifts associated with convulsive seizures and brain monoamine changes in rabbits.
Topics: 5-Hydroxytryptophan; Adolescent; Animals; Bemegride; Brain Damage, Chronic; Caudate Nucleus; Cerebra | 1977 |
[Ramsay-Hunt syndrome and aniridia in 2 monozygotic twins].
Topics: 5-Hydroxytryptophan; Adolescent; Benzodiazepinones; Blood Group Antigens; Cerebellar Ataxia; Disease | 1975 |
Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine | 1992 |
Serotonergic mechanism in hippocampal kindled seizures.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Cats; | 1992 |
Suppression of penicillin-induced epileptiform activity by noxious stimulation: mediation by 5-hydroxytryptamine.
Topics: 5-Hydroxytryptophan; Animals; Cerebral Cortex; Epilepsy; Fenclonine; Locus Coeruleus; Male; Membrane | 1986 |
Behavioural and electrographic effects of L-5-hydroxytryptophan and D, L-parachlorophenyl-alanine on epileptic Senegalese baboon (Papio papio).
Topics: 5-Hydroxytryptophan; Animals; Brain; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Fenc | 1972 |
Electroretinogram and afferent visual transmission in the epileptic baboon Papio papio. Effects of drugs influencing monoaminergic systems.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Dihydroxyphenylalanine; Electroretinography; Epilepsy | 1973 |
[Observations on the use of 5 HTP in clinical medicine].
Topics: 5-Hydroxytryptophan; Epilepsy; Humans; Male; Mental Disorders; Movement Disorders; Myoclonus; Thinki | 1972 |
[On the probable pathogenetic mechanisms of epilepsy].
Topics: 5-Hydroxytryptophan; Alanine; Ammonia; Animals; Asparagine; Carboxy-Lyases; Epilepsy; Glutamates; Li | 1967 |